Literature DB >> 17437422

Lymphocyte-hepatic stellate cell proximity suggests a direct interaction.

N Muhanna1, A Horani, S Doron, R Safadi.   

Abstract

Recent functional research studies suggest an anti-fibrotic role for natural killer (NK) cells coupled with a profibrotic role for CD8 cells. However, the morphological cellular interplay between the different cell types is less clear. To investigate lymphocyte/hepatic stellate cell (HSC) interactions, hepatic fibrosis was induced by administering carbon tetrachloride (CCl4) intraperitoneally (i.p.) for 4 weeks in C57Bl/6 mice. Animals were killed at 0, 1, 2, 3 and 4 weeks. Liver sections were stained for Sirius red. Confocal microscopy was used to evaluate alpha smooth-muscle actin (alphaSMA) and lymphocyte subsets in liver sections. At weeks 0 and 4, liver protein extracts were assessed for alphaSMA by Western blotting and isolated liver lymphocytes as well as HSC were analysed by fluorescence activated cell sorter (FACS). Similar to the results obtained from classical Sirius red staining and alphaSMA blotting, analysis of liver sections by confocal microscopy revealed a marked and continuous accumulation of alphaSMA staining along sequential experimental check-points after administering CCl4. Although the number of all liver lymphocyte subsets increased following fibrosis induction, FACS analysis revealed an increase in the distribution of liver CD8 subsets and a decrease of CD4 T cells. Confocal microscopy showed a significant early appearance of CD8 and NK cells, and to a lesser extent CD4 T cells, appearing only from week 2. Lymphocytes were seen in proximity only to HSC, mainly in the periportal area and along fibrotic septa, suggesting a direct interaction. Notably, lymphocyte subsets were undetectable in naive liver sections. Freshly isolated HCS show high expression of major histocompatibility complex (MHC) class II and CD11c. In the animal model of hepatic fibrosis, lymphocytes infiltrate into the liver parenchyma and it is thought that they attach directly to activated HSC. Because HSCs express CD11c/class II molecules, interactions involving them might reflect that HSCs have an antigen-presenting capacity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437422      PMCID: PMC1868876          DOI: 10.1111/j.1365-2249.2007.03353.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Induction of Mx-2 in rat liver by toxic injury.

Authors:  Danko S Batusic; Thomas Armbrust; Bernhard Saile; Giuliano Ramadori
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

Review 2.  Cell adhesion and migration. IV. Lymphocyte trafficking in the intestine and liver.

Authors:  M Salmi; D Adams; S Jalkanen
Journal:  Am J Physiol       Date:  1998-01

3.  Chronic alcoholism is associated with an imbalanced production of Th-1/Th-2 cytokines by peripheral blood T cells.

Authors:  F J Laso; C Iglesias-Osma; J Ciudad; A López; I Pastor; A Orfao
Journal:  Alcohol Clin Exp Res       Date:  1999-08       Impact factor: 3.455

4.  Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis.

Authors:  K Thompson; J Maltby; J Fallowfield; M McAulay; H Millward-Sadler; N Sheron
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

5.  Signal transduction and the regulation of actin conformation during myeloid maturation: studies in HL60 cells.

Authors:  R L Sham; C H Packman; C N Abboud; M A Lichtman
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

6.  Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

Authors:  Alaa Melhem; Nidal Muhanna; Amal Bishara; Carlos E Alvarez; Yaron Ilan; Taiser Bishara; Amjad Horani; Mithal Nassar; Scott L Friedman; Rifaat Safadi
Journal:  J Hepatol       Date:  2006-02-08       Impact factor: 25.083

7.  Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1.

Authors:  T Knittel; M Mehde; D Kobold; B Saile; C Dinter; G Ramadori
Journal:  J Hepatol       Date:  1999-01       Impact factor: 25.083

8.  Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.

Authors:  Rifaat Safadi; Masayuki Ohta; Carlos E Alvarez; M Isabel Fiel; Meena Bansal; Wajahat Z Mehal; Scott L Friedman
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

9.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Comparative quantitative analysis of macrophage populations defined by CD68 and carbohydrate antigens in normal and pathologically altered human liver tissue.

Authors:  S E Baldus; T K Zirbes; I C Weidner; U Flucke; E Dittmar; J Thiele; H P Dienes
Journal:  Anal Cell Pathol       Date:  1998       Impact factor: 2.916

View more
  31 in total

1.  Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.

Authors:  Anna Baghdasaryan; Thierry Claudel; Astrid Kosters; Judith Gumhold; Dagmar Silbert; Andrea Thüringer; Katharina Leski; Peter Fickert; Saul J Karpen; Michael Trauner
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

2.  Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.

Authors:  Miroslaw Kornek; Yury Popov; Towia A Libermann; Nezam H Afdhal; Detlef Schuppan
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

Review 3.  Hepatic inflammation and fibrosis: functional links and key pathways.

Authors:  Ekihiro Seki; Robert F Schwabe
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

4.  Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease.

Authors:  Valentina Medici; Mohamed R Ali; Suk Seo; Christopher A Aoki; Lorenzo Rossaro; Kyoungmi Kim; Will D Fuller; Tamas J Vidovszky; William Smith; Joy X Jiang; Kalyani Maganti; Peter J Havel; Amit Kamboj; Rajendra Ramsamooj; Natalie J Török
Journal:  Obesity (Silver Spring)       Date:  2010-05-06       Impact factor: 5.002

Review 5.  The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Food Chem Toxicol       Date:  2020-07-05       Impact factor: 6.023

6.  [Characteristics of peripheral rheograms following thermal provocation in normal and pathologic pregnancy].

Authors:  A Feiks; C Nowotny; W Gruber
Journal:  Geburtshilfe Frauenheilkd       Date:  1988-09       Impact factor: 2.915

7.  Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.

Authors:  Ana C Tuyama; Feng Hong; Yedidya Saiman; Chuansheng Wang; Derya Ozkok; Arevik Mosoian; Ping Chen; Benjamin K Chen; Mary E Klotman; Meena B Bansal
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

Review 8.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

9.  Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity.

Authors:  Sheng Zhang; Weiyi Huang
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-26       Impact factor: 4.553

Review 10.  Mononuclear cells in liver fibrosis.

Authors:  Fabio Marra; Sara Aleffi; Sara Galastri; Angela Provenzano
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.